Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
75.17
-4.97 (-6.20%)
At close: Oct 10, 2025, 4:00 PM EDT
76.00
+0.83 (1.10%)
After-hours: Oct 10, 2025, 7:57 PM EDT
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 14 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $154, which forecasts a 104.87% increase in the stock price over the next year. The lowest target is $89 and the highest is $255.
Price Target: $154 (+104.87%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 2 | 2 |
| Buy | 7 | 7 | 7 | 5 | 6 | 6 |
| Hold | 3 | 3 | 3 | 6 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $150 → $125 | Buy | Maintains | $150 → $125 | +66.29% | Oct 7, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $230 → $89 | Strong Buy → Hold | Downgrades | $230 → $89 | +18.40% | Sep 22, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $150 | Buy | Initiates | $150 | +99.55% | Sep 2, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $116 → $97 | Hold | Maintains | $116 → $97 | +29.04% | Aug 15, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $149 → $116 | Hold | Maintains | $149 → $116 | +54.32% | Aug 5, 2025 |
Financial Forecast
Revenue This Year
922.05M
from 802.80M
Increased by 14.85%
Revenue Next Year
1.06B
from 922.05M
Increased by 14.64%
EPS This Year
0.50
from 1.75
Decreased by -71.34%
EPS Next Year
1.63
from 0.50
Increased by 225.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 952.5M | 1.1B | |||
| Avg | 922.1M | 1.1B | |||
| Low | 882.0M | 989.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.6% | 21.8% | |||
| Avg | 14.9% | 14.6% | |||
| Low | 9.9% | 7.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.07 | 3.02 | |||
| Avg | 0.50 | 1.63 | |||
| Low | 0.38 | 1.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -38.8% | 503.0% | |||
| Avg | -71.3% | 225.5% | |||
| Low | -78.2% | 116.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.